Loading...
Market
Global response to US decoupling from Chinese biotechs by end of 2024
5
Resolution / Starting Odds
Follow U.S. policy • 33%
Reject U.S. policy • 33%
Stay neutral • 33%
Official government statements or credible international news sources
Story
U.S. House Sets 2032 Deadline for Decoupling with WuXi AppTec, Other Chinese Biotechs
May 10, 2024, 05:30 PM
The U.S. House of Representatives has revised the Biosecure Act, setting a new 2032 decoupling deadline for American drugmakers to sever ties with Chinese biotechnology firms such as WuXi AppTec and WuXi Biologics. Originally, the bill proposed a more rapid decoupling from Chinese biotechs, which raised concerns among stakeholders about potential negative impacts on patients and biopharmaceutical companies. A survey by @IAmBiotech highlighted these concerns. Additionally, WuXi AppTec has been actively contesting the claims made in the anti-China biotech bills, asserting its role in bolstering U.S. biomanufacturing.
View original story
Similar markets
Support U.S. Actions • 33%
Oppose U.S. Actions • 33%
Remain Neutral • 34%
More firms investigated • 25%
Sanctions imposed • 25%
No significant actions • 25%
Other actions • 25%
Yes • 50%
No • 50%
Condemnation by WHO • 33%
Condemnation by ASEAN • 33%
No formal condemnation • 33%
No significant international reaction • 34%
Economic or trade measures against the U.S. • 33%
Supportive statements or actions from other countries • 33%
UN resolution condemning the act • 25%
Increased scrutiny on U.S. activities • 25%
No significant reaction • 25%
Increased support for China's initiatives • 25%
Support • 33%
Criticism • 33%
Neutral • 33%
Increased scrutiny and sanctions • 25%
Diplomatic negotiations without sanctions • 25%
No change in current policies • 25%
Enhanced cooperative scientific investigation • 25%
Support from other nations • 33%
Neutral response from other nations • 33%
Opposition from other nations • 34%
EU takes similar actions • 25%
China retaliates against U.S. companies • 25%
No significant international reactions • 25%
Other Asian countries impose restrictions • 25%